换一批
换一批SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study.
作者：
Laura Augusta,Gonella [1]
;
Francesca,Moretti [2]
;
Annalisa,Capuano [3]
;
Caterina,De Sarro [4]
;
Lorenza,Ferrara [5]
;
Elisabetta,Geninatti [6]
;
Greta,Guarnieri [7]
;
Xhikjana,Hysolakoj [8]
;
Margherita,Lalli [9]
;
Olivia,Leoni [10]
;
Antea Maria Pia,Mangano [11]
;
Patrizia,Marani Toro [12]
;
Viviana,Mecchia [8]
;
Maria Caterina,Merlano [13]
;
Caterina,Palleria [4]
;
Anna Maria,Potenza [14]
;
Paola,Rossi [8]
;
Marco,Rossi [15]
;
Francesca,Sanità [16]
;
Ester,Sapigni [14]
;
Cristina,Scavone [3]
;
Claudia,Sommaro [8]
;
Marco,Tuccori [17]
;
Giovanna,Zanoni [18]
;
Ugo,Moretti [1]
;
VigiVax Working Group
作者单位：
Section of Pharmacology, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.
[1]
Section of Hygiene and Environmental Occupational Preventive Medicine, Department of Diagnostics and Public Health, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.
[2]
Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via Costantinopoli 16, 80138 Napoli, Italy.
[3]
Unit of Clinical Pharmacology and Pharmacovigilance, "Renato Dulbecco" University Hospital, Research Center FAS@UMG, Department of Health Science, Magna Graecia University, 88100 Catanzaro, Italy.
[4]
Local Unit Health of Asti, Via Conte Verde 125, 14100 Asti, Italy.
[5]
Regional Center of Pharmacovigilance, Piemonte Region, Via Silvio Pellico 19, 10125 Torino, Italy.
[6]
Unit of Pharmacovigilance & Clinical Research, ASST Fatebenefratelli-Sacco, Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, 20157 Milan, Italy.
[7]
Regional Center of Pharmacovigilance-Friuli Venezia Giulia Region, Department of Central Health, Social and Disability Policies, Via Cassa di Risparmio 10, 34100 Trieste, Italy.
[8]
U.O.C. Farmaceutica Territoriale, Azienda Sanitaria Territoriale di Macerata, Belvedere Raffaello Sanzio 1, 62100 Macerata, Italy.
[9]
Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Welfare General Directorate, Lombardy Region, Piazza Città di Lombardia 1, 20124 Milan, Italy.
[10]
Regional Center of Pharmacovigilance, Marche Region, Via Gentile da Fabriano, 60125 Ancona, Italy.
[11]
Health Office, Epidemiology and Public Health, ASL Pescara, Regional Department of Prevention Abruzzo, Via R. Paolini, 47, 65100 Pescara, Italy.
[12]
ALISA/Liguria Region, Via Gabriele D Annunzio 64, 16121 Genova, Italy.
[13]
Regional Center for Pharmacovigilance, Emilia-Romagna Region, Medicines and Medical Devices Governance Area, Hospital Care Sector, General Directorate for Personal Care, Health and Welfare, Viale Aldo Moro 21, 40127 Bologna, Italy.
[14]
Department of Medical, Surgical and Neuroscience Sciences, University of Siena, Viale Mario Bracci 16, 53100 Siena, Italy.
[15]
Territorial Assistance Service, ASL Pescara, Regional Center of Pharmacovigilance, Abruzzo, Via R. Paolini 47, 65100 Pescara, Italy.
[16]
Unit of Adverse Drug Reaction Monitoring, University Hospital of Pisa, Via Roma 55, 56126 Pisa, Italy.
[17]
Immunology Unit, Pathology and Diagnostics Department, University Hospital of Verona, 37134 Verona, Italy.
[18]
DOI
10.3390/vaccines12091076
PMID
39340106
发布时间
2024-09-30
- 浏览0
Vaccines
Vaccines
2024年12卷9期
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
